The Effect of Rosuvastatin on Low-Density Lipoprotein Subfractions in Patients With Impaired Fasting Glucose

Conclusion:
Targeting dyslipidemia with rosuvastatin was associated with more favorable changes in the LDL subfraction profile in patients with IFG compared to normoglycemic ones.

Source: Journal of Cardiovascular Pharmacology and Therapeutics - April 15, 2015 Category: Cardiology Authors: Rizos, C. V., Kostapanos, M. S., Rizos, E. C., Tselepis, A. D., Elisaf, M. S. Tags: Clinical Studies Source Type: research